Introduction: Anti-adhesion therapy in sickle cell disease

Blood

Volumn 95, Issue 2, 2000, Pages 365-367

  Harlan, John M ^a,b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTEGRIN RECEPTOR; THROMBOCYTE ACTIVATING FACTOR; THROMBOSPONDIN; VON WILLEBRAND FACTOR;

CAPILLARY ENDOTHELIUM; CELL ADHESION; CELL INTERACTION; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IMAGE ANALYSIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SHORT SURVEY; SICKLE CELL ANEMIA; VEIN OCCLUSION;

EID: 0034650972     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v95.2.365     Document Type: Short Survey

References (33)

1. Kaut DK, Tsai HM. Liu XD, Nakada MT, Nagel RL, Coller BS. Monoclonal antibodies to aV3 (7E3 and LM609) inhibit sickle red blood cell-endothelium interactions induced by platelet-activating factor. Blood. 1999:94:1.
2. Hebbel RP. Adhesive interactions of sickle erythrocytes with endothelium. J Clin Invest 1997; 100:583.
3. Solovey A, Lin Y, Browne P, Choong S, Wayner E, Hebbel RP. Circulating activated endothelial cells in sickle cell anemia. N Engl J Med. 1997;337: 1584.
4. Hebbel RP, Yamada O, Moldow CF, Jacob HS, White JG, Eaton JW. Abnormal adherence of sickle erythrocytes to cultured vascular endothelium: possible mechanism for microvascular occlusion in sickle cell disease. J Clin Invest. 1980; 65:154.
5. Hoover R, Rubin R, Wise G, Warren R. Adhesion of normal and sickle erythrocytes to endothelial monolayer cultures. Blood. 1979;54:872.
6. Hebbel RP, Boogaerts MA, Eaton JW, Steinberg MH. Erythrocyte adherence to endothelium in sickle-cell anemia. A possible determinant of disease severity. N Engl J Med. 1980:302:992.
7. Bunn HF. Pathogenesis and trealment of sickle cell disease. N Engl J Med. 1997:337:762.
8. Joneckis CC, Ackley RL, Orringer EP, Wayner EA, Parise LV. Integrin alpha 4 beta 1 and glycoprotein IV (CD36) are expressed on circulating reticulocytes in sickle cell anemia. Blood. 1993; 82:3548.
9. Swerlick RA, Eckman JH, Kumar A, Jeitler M, Wick TM. Alpha 4 beta 1 -integrin expression on sickle reticulocytes: vascular cell adhesion molecule-1-dependent binding to endothelium. Blood. 1993:82:1891.
10. Sugihara K, Sugihara T, Mohandas N, Hebbel RP. Thrombospondin mediates adherence of CD36+ sickle reticulocytes to endothelial cells. Blood. 1992:80:2634.
11. Styles LA, Lubin B, Vichinsky E, et al. Decrease of very late activation antigen-4 and CD36 on reticulocytes in sickle cell patients treated with hydroxyurea. Blood. 1997;89:2554.
12. Thevenin BJM, Crandall I, Ballas SK, Sherman IW, Shohet SB. Band 3 peptides block the adherence of sickle cells to endothelial cells in vitro. Blood. 1997:90:4172.
13. Gee BE, Platt OS. Sickle reticulocytes adhere to VCAM-1. Blood. 1995:85:268.
14. Setty BN, Stuart MJ. Vascular cell adhesion molecule-1 is involved in mediating hypoxia-induced sickle red blood cell adherence to endothelium: potential role in sickle cell disease. Blood. 1996; 88:2311.
15. Brittain HA, Eckman JR, Swerlick RA, Howard RJ, Wick TM. Thrombospondin from activated platelets promotes sickle erythrocyte adherence to human microvascular endothelium under physiologic flow: a potential role for platelet activation in sickle cell vaso-occlusion. Blood. 1993:81:2137.
16. Kaul DK, Chen D, Zhan J. Adhesion of sickle cells to vascular endothelium is critically dependent on. changes in density and shape of the cells. Blood. 1994;83:3006.
17. WickTM, Moake JL, Udden MM, Eskin SG, Sears DA, Mclntire LV. Unusually large von Willebrand factor multimers increase adhesion of sickle erythrocytes to human endothelial cells under controlled flow. J Clin Invest. 1987;80:905.
18. Hillery CA, Du MC, Montgomery RR, Scott JP. Increased adhesion of erythrocytes to components of the extracellular matrix: isolation and characterization of a red blood cell lipid that binds thrombospondin and laminin. Blood. 1996:87: 4879.
19. Udani M, Zen Q, Cottman M, et al. Basal cell adhesion molecule/Iutheran protein. The receptor critical for sickle cell adhesion to laminin. J Clin Invest. 1998:101:2550.
20. Kasschau MR, Barabino GA, Bridges KR, Golan DE. Adhesion of sickle neutrophils and erythrocytes to fibronectin. Blood. 1996:87:771.
21. Manodori AB, Matsui NM, Chen JY, Embury SH. Enhanced adherence of sickle erythrocytes to thrombin-treated endothelial cells involves interendothelial cell gap formation. Blood. 1998;92: 3445.
22. Roberts DD, Williams SB, Gralnick HR, Ginsburg V. Von Willebrand factor binds specifically to sulfated glycolipids. J Biol Chem. 1986:261:3306.
23. Fabry ME. Fine E, Raj'anayagam V, et al. Demonstration of endothelial adhesion of sickle cells in vivo: a distinct role for deformable sickle cell discocytes. Blood. 1992:79:1602.
24. Carlos TM, Harten JM. Leukocyte-endothelial adhesion molecules. Blood. 1994:84:2068.
25. Kaul DK, Fabry ME, Nagel RL. Microvascular sites and characteristics of sickle cell adhesion to vascular endothelium in shear (low conditions: pathophysiological implications. Proc Natl Acad Sei U S A. 1989:86:3356.
26. Kaul DK, Fabry ME, Costantini F, Rubin EM, Nagel RL In vivo demonstration of red ceil-endotheiial interaction, sickling and altered microvascular response to oxygen in the sickle transgenic mouse. J Clin Invest. 1995:96:2845.
27. Kaul DK, Nagel RL, Chen D, Tsai HM. Sickle erythrocyte-endothelial interactions in microcirculation: the role of von Willebrand factor and implications for vasoocclusion. Blood. 1993;81:2429.
28. Kumar A, Eckman JR, Wick TM. Inhibition of plasma-mediated adherence of sickle erythrocytes to microvascular endothelium by conformationally constrained RGD-containing peptides. -Am 3 Hematol. 1996:53:92.
29. Conforti G, Dominguez-Jimenez C, Zanetti A, et al. Human endothelial cells express integrin receptors on the luminal aspect of their membrane. Blood. 1992;80:437.
30. Coller BS. Platelet GPIIb/IIla antagonists: the first anti-integrin receptor therapeutics. J Clin Invest. 1997;100:S57.
31. Coller BS. Potential non-glycoprotein llb/llla effects of abciximab. Am Heart J. 1999; 38:S1.
32. Cornejo CJ, Winn RK, Marian JM. Anti-adhesion therapy. Adv Pharmacol. 1997;39:99.
33. Eliceiri BP, Cheresh DA. The role of alphaV integrins during angiogenesis: insights into potential mechanisms of action and clinical development. J Clin Invest. 1999;103:1227.